GL1X · GenesisL1 explorer

MolNFT v1 · #137301 · protein

Crystal structure of mcl-1 in complex with a bim competitive inhibitor

5VKC · Induced myeloid leukemia cell differentiation protein mcl- 1: “Crystal structure of mcl-1 in complex with a bim competitive inhibitor”. X-ray diffraction, 2 ligands (9EA, ZN), 2 pockets (best druggability 0.64). MolNFT v1 #137301 on…

PDB
5VKC
Type
protein
Length
288 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Induced myeloid leukemia cell differentiation protein mcl- 1
UniProt
Q07820
Ligands
9EA, ZN
Pockets
2 · best druggability 0.64

Structure

x-ray diffraction · 1 distinct chain · 81% helix, 0% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BInduced myeloid leukemia cell differentiation protein mcl- 1protein14481% helix, 0% strandQ07820

Ligands and binding sites

  • 9EA · 7-(3-{[4-(4-acetylpiperazin-1-yl)phenoxy]methyl}-1,5-dimethyl-1H-pyrazol-4-yl)-3-{3-[(naphthalen-1-yl) oxy]propyl}-1-[(pyridin-3-yl)methyl]-1H-indole-2-carboxylic acid · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 10 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12340.640.82259EA
21510.640.85179EA

Interfaces

1 interface between chains.

  • A–B · 222 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 5VKC · Crystal structure of MCL-1 in complex with a BIM competitive inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.